schliessen

Filtern

 

Bibliotheken

OUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE

Aims: The prognostic outcome of patients with amyloidosis who receive a kidney transplant is controversial. The aim of the study was to analyze the renal transplantation outcome of patients with amyloidosis compared to transplant recipients with other kidney diseases. Methods: Among 940 patients who... Full description

Journal Title: International Journal of Artificial Organs Jun 2012, Vol.35(6), pp.444-449
Main Author: Gursu, M
Other Authors: Yelken, B , Caliskan, Y , Kazancioglu, R , Yazici, H , Kilicaslan, I , Turkmen, A , Sever, M
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0391-3988 ; DOI: 10.5301/ijao.5000091
Link: http://search.proquest.com/docview/1268653443/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1268653443
title: OUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
format: Article
creator:
  • Gursu, M
  • Yelken, B
  • Caliskan, Y
  • Kazancioglu, R
  • Yazici, H
  • Kilicaslan, I
  • Turkmen, A
  • Sever, M
subjects:
  • Amyloidosis
  • Tissue Engineering
ispartof: International Journal of Artificial Organs, Jun 2012, Vol.35(6), pp.444-449
description: Aims: The prognostic outcome of patients with amyloidosis who receive a kidney transplant is controversial. The aim of the study was to analyze the renal transplantation outcome of patients with amyloidosis compared to transplant recipients with other kidney diseases. Methods: Among 940 patients who had renal transplantation in our unit between 1983 and 2009, 44 patients with amyloidosis were compared regarding early and late complications and survival, retrospectively, with a control group of 41 consecutive patients with the same donor type and a matched renal transplantation date. Results: The groups were similar regarding demographic parameters, HLA mismatch numbers and mean follow-up period. Groups were similar regarding early and late infectious and non-infectious complications, except recurrence of the primary disease, which was more common in the amyloidosis group. As the cause of graft loss, rejection (acute or chronic) was more common in the control group; whereas primary non-functioning graft, and death with a functioning graft were more common in the amyloidosis group. Patient survival rates at 1, 5, and 10 years were 87.6%, 78.1%, and 62.3 in the amyloidosis group; and 93.2%, 82.6%, and 69.3% in the control group. Graft survival rates at 1, 5 and 10 years were 87.6%, 75.4%, 56.4% in the amyloidosis group; and 93.2%, 80.3%, and 60.6% in the control group, respectively. These values did not show any statistical difference. Conclusions: The outcomes of renal transplantation in patients with amyloidosis are comparable with recipients whose primary problems are due to other kidney diseases; therefore, amyloidosis patients should be accepted as good candidates for transplantation.
language: eng
source:
identifier: ISSN: 0391-3988 ; DOI: 10.5301/ijao.5000091
fulltext: no_fulltext
issn:
  • 03913988
  • 0391-3988
url: Link


@attributes
ID43886122
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1268653443
sourceidproquest
recordidTN_proquest1268653443
sourcesystemOther
pqid1268653443
display
typearticle
titleOUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
creatorGursu, M ; Yelken, B ; Caliskan, Y ; Kazancioglu, R ; Yazici, H ; Kilicaslan, I ; Turkmen, A ; Sever, M
contributorGursu, M (correspondence author)
ispartofInternational Journal of Artificial Organs, Jun 2012, Vol.35(6), pp.444-449
identifierISSN: 0391-3988 ; DOI: 10.5301/ijao.5000091
subjectAmyloidosis ; Tissue Engineering
descriptionAims: The prognostic outcome of patients with amyloidosis who receive a kidney transplant is controversial. The aim of the study was to analyze the renal transplantation outcome of patients with amyloidosis compared to transplant recipients with other kidney diseases. Methods: Among 940 patients who had renal transplantation in our unit between 1983 and 2009, 44 patients with amyloidosis were compared regarding early and late complications and survival, retrospectively, with a control group of 41 consecutive patients with the same donor type and a matched renal transplantation date. Results: The groups were similar regarding demographic parameters, HLA mismatch numbers and mean follow-up period. Groups were similar regarding early and late infectious and non-infectious complications, except recurrence of the primary disease, which was more common in the amyloidosis group. As the cause of graft loss, rejection (acute or chronic) was more common in the control group; whereas primary non-functioning graft, and death with a functioning graft were more common in the amyloidosis group. Patient survival rates at 1, 5, and 10 years were 87.6%, 78.1%, and 62.3 in the amyloidosis group; and 93.2%, 82.6%, and 69.3% in the control group. Graft survival rates at 1, 5 and 10 years were 87.6%, 75.4%, 56.4% in the amyloidosis group; and 93.2%, 80.3%, and 60.6% in the control group, respectively. These values did not show any statistical difference. Conclusions: The outcomes of renal transplantation in patients with amyloidosis are comparable with recipients whose primary problems are due to other kidney diseases; therefore, amyloidosis patients should be accepted as good candidates for transplantation.
languageeng
source
version5
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1268653443/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Gursu, M
1Yelken, B
2Caliskan, Y
3Kazancioglu, R
4Yazici, H
5Kilicaslan, I
6Turkmen, A
7Sever, M
titleOUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
descriptionAims: The prognostic outcome of patients with amyloidosis who receive a kidney transplant is controversial. The aim of the study was to analyze the renal transplantation outcome of patients with amyloidosis compared to transplant recipients with other kidney diseases. Methods: Among 940 patients who had renal transplantation in our unit between 1983 and 2009, 44 patients with amyloidosis were compared regarding early and late complications and survival, retrospectively, with a control group of 41 consecutive patients with the same donor type and a matched renal transplantation date. Results: The groups were similar regarding demographic parameters, HLA mismatch numbers and mean follow-up period. Groups were similar regarding early and late infectious and non-infectious complications, except recurrence of the primary disease, which was more common in the amyloidosis group. As the cause of graft loss, rejection (acute or chronic) was more common in the control group; whereas primary non-functioning graft, and death with a functioning graft were more common in the amyloidosis group. Patient survival rates at 1, 5, and 10 years were 87.6%, 78.1%, and 62.3 in the amyloidosis group; and 93.2%, 82.6%, and 69.3% in the control group. Graft survival rates at 1, 5 and 10 years were 87.6%, 75.4%, 56.4% in the amyloidosis group; and 93.2%, 80.3%, and 60.6% in the control group, respectively. These values did not show any statistical difference. Conclusions: The outcomes of renal transplantation in patients with amyloidosis are comparable with recipients whose primary problems are due to other kidney diseases; therefore, amyloidosis patients should be accepted as good candidates for transplantation.
subject
0Amyloidosis
1Tissue Engineering
2W 30920
general
0English
110.5301/ijao.5000091
2Engineering Research Database
3Technology Research Database
4ProQuest Biological Science Collection
5ProQuest Engineering Collection
6ProQuest Environmental Science Collection
7ProQuest Natural Science Collection
8ProQuest Technology Collection
9ProQuest SciTech Collection
10Agricultural & Environmental Science Database
11Biological Science Database
12Materials Science & Engineering Database
13Natural Science Collection
14SciTech Premium Collection
15Technology Collection
sourceidproquest
recordidproquest1268653443
issn
003913988
10391-3988
rsrctypearticle
creationdate2012
addtitleInternational Journal of Artificial Organs
searchscope
01007443
11007944
210000004
310000005
410000013
510000015
610000022
710000038
810000041
910000043
1010000050
1110000053
1210000120
1310000198
1410000209
1510000217
1610000234
1710000238
1810000250
1910000253
2010000260
2110000265
22proquest
scope
01007443
11007944
210000004
310000005
410000013
510000015
610000022
710000038
810000041
910000043
1010000050
1110000053
1210000120
1310000198
1410000209
1510000217
1610000234
1710000238
1810000250
1910000253
2010000260
2110000265
22proquest
lsr43
01007443false
11007944false
210000004false
310000005false
410000013false
510000015false
610000022false
710000038false
810000041false
910000043false
1010000050false
1110000053false
1210000120false
1310000198false
1410000209false
1510000217false
1610000234false
1710000238false
1810000250false
1910000253false
2010000260false
2110000265false
contributorGursu, M
startdate20120601
enddate20120601
citationpf 444 pt 449 vol 35 issue 6
lsr30VSR-Enriched:[date, eissn, pqid]
sort
titleOUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
authorGursu, M ; Yelken, B ; Caliskan, Y ; Kazancioglu, R ; Yazici, H ; Kilicaslan, I ; Turkmen, A ; Sever, M
creationdate20120601
lso0120120601
facets
frbrgroupid4968703878352802614
frbrtype5
languageeng
creationdate2012
topic
0Amyloidosis
1Tissue Engineering
collection
0Engineering Research Database
1Technology Research Database
2ProQuest Biological Science Collection
3ProQuest Engineering Collection
4ProQuest Environmental Science Collection
5ProQuest Natural Science Collection
6ProQuest Technology Collection
7ProQuest SciTech Collection
8Agricultural & Environmental Science Database
9Biological Science Database
10Materials Science & Engineering Database
11Natural Science Collection
12SciTech Premium Collection
13Technology Collection
prefilterarticles
rsrctypearticles
creatorcontrib
0Gursu, M
1Yelken, B
2Caliskan, Y
3Kazancioglu, R
4Yazici, H
5Kilicaslan, I
6Turkmen, A
7Sever, M
jtitleInternational Journal of Artificial Organs
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
aulast
0Gursu
1Yelken
2Caliskan
3Kazancioglu
4Yazici
5Kilicaslan
6Turkmen
7Sever
aufirst
0M
1B
2Y
3R
4H
5I
6A
au
0Gursu, M
1Yelken, B
2Caliskan, Y
3Kazancioglu, R
4Yazici, H
5Kilicaslan, I
6Turkmen, A
7Sever, M
addauGursu, M
atitleOUTCOME OF PATIENTS WITH AMYLOIDOSIS AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
jtitleInternational Journal of Artificial Organs
risdate20120601
volume35
issue6
spage444
epage449
pages444-449
issn0391-3988
formatjournal
genrearticle
ristypeJOUR
abstractAims: The prognostic outcome of patients with amyloidosis who receive a kidney transplant is controversial. The aim of the study was to analyze the renal transplantation outcome of patients with amyloidosis compared to transplant recipients with other kidney diseases. Methods: Among 940 patients who had renal transplantation in our unit between 1983 and 2009, 44 patients with amyloidosis were compared regarding early and late complications and survival, retrospectively, with a control group of 41 consecutive patients with the same donor type and a matched renal transplantation date. Results: The groups were similar regarding demographic parameters, HLA mismatch numbers and mean follow-up period. Groups were similar regarding early and late infectious and non-infectious complications, except recurrence of the primary disease, which was more common in the amyloidosis group. As the cause of graft loss, rejection (acute or chronic) was more common in the control group; whereas primary non-functioning graft, and death with a functioning graft were more common in the amyloidosis group. Patient survival rates at 1, 5, and 10 years were 87.6%, 78.1%, and 62.3 in the amyloidosis group; and 93.2%, 82.6%, and 69.3% in the control group. Graft survival rates at 1, 5 and 10 years were 87.6%, 75.4%, 56.4% in the amyloidosis group; and 93.2%, 80.3%, and 60.6% in the control group, respectively. These values did not show any statistical difference. Conclusions: The outcomes of renal transplantation in patients with amyloidosis are comparable with recipients whose primary problems are due to other kidney diseases; therefore, amyloidosis patients should be accepted as good candidates for transplantation.
doi10.5301/ijao.5000091
urlhttp://search.proquest.com/docview/1268653443/
eissn17246040
date2012-06